SCHEMBL7599478

SCHEMBL7599478

ClC(Cl)C(Cl)(Cl)C(Cl)(Cl)C(Cl)Cl

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP2E1 P05181 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL147892 0.80
SCHEMBL392319 0.74
SCHEMBL1997824 0.74 ALDH1A1 (0.33) ALDH1A1
SCHEMBL833468 0.74
SCHEMBL1993226 0.74 ALDH1A1 (0.33) ALDH1A1
SCHEMBL3969943 0.74
SCHEMBL21434478 0.74 ALDH1A1 (0.33) ALDH1A1
SCHEMBL834985 0.74
SCHEMBL395094 0.71
Pentachloroethane SCHEMBL4728 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9328042-B2 Integrated process for the production of Z-1,1,1,4,4,4-hexafluoro-2-butene THE CHEMOURS COMPANY FC, LLC (US) 2016-05-03 US claimed
US-20160039728-A1 INTEGRATED PROCESS FOR THE PRODUCTION OF Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2016-02-11 US claimed
US-20240234031-A1 SEMICONDUCTOR DEVICE AND SEMICONDUCTOR APPARATUS AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-07-11 US disclosed
US-9328042-B2 Integrated process for the production of Z-1,1,1,4,4,4-hexafluoro-2-butene THE CHEMOURS COMPANY FC, LLC (US) 2016-05-03 US disclosed
US-20160039728-A1 INTEGRATED PROCESS FOR THE PRODUCTION OF Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2016-02-11 US disclosed
EP-0968157-B1 COMPOSITION FOR GENERATING SMOKE TNO (NL) 2002-11-13 EP disclosed
US-6414040-B1 CHLORINATED COMPOUNDS AND GROUP 2A METAL OR OXIDE MIXTURE NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2002-07-02 US disclosed
EP-0968157-A1 COMPOSITION FOR GENERATING SMOKE NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2000-01-05 EP disclosed
WO-1998040330-A1 COMPOSITION FOR GENERATING SMOKE NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 1998-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039728-A1 INTEGRATED PROCESS FOR THE PRODUCTION OF Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE ZYX, FBP1, ZDHHC2 LMNA 3448/4885ALDH1A1 154/4885CYP2E1 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.